---
annotations:
- id: DOID:2394
  parent: disease of cellular proliferation
  type: Disease Ontology
  value: ovarian cancer
- id: PW:0000605
  parent: disease pathway
  type: Pathway Ontology
  value: cancer pathway
- id: PW:0000003
  parent: signaling pathway
  type: Pathway Ontology
  value: signaling pathway
- id: PW:0000013
  parent: disease pathway
  type: Pathway Ontology
  value: disease pathway
authors:
- Khanspers
- MaintBot
- Susan
- Lindarieswijk
- AlexanderPico
- Fehrhart
- Eweitz
- Egonw
citedin:
- link: PMC9440113
  title: Machine learning and bioinformatics to identify 8 autophagy-related biomarkers
    and construct gene regulatory networks in dilated cardiomyopathy (2022)
- link: PMC9614744
  title: Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin
    D (2022)
- link: 10.3389/fimmu.2021.769011
  title: 'A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin
    Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics
    Analysis (2024)'
communities:
- ExRNA
description: Interplay of RAC1, p38 MAPK, PAK1 and MMP2 in cell signaling pathways
  downstream of TEK receptor activity related to tumor growth, angiogenesis, and cell
  proliferation. These processes are reduced in RAC1 inactivated models of ovarian
  cancer. Gonzalez-Villasana, et al. Clin Cancer Res, 2015.   Proteins on this pathway
  have targeted assays available via the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3303
  ).
last-edited: 2025-03-03
ndex: b754929b-8b66-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3303
- /instance/WP3303
- /instance/WP3303_r137162
revision: r137162
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3303.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Interplay of RAC1, p38 MAPK, PAK1 and MMP2 in cell signaling pathways
    downstream of TEK receptor activity related to tumor growth, angiogenesis, and
    cell proliferation. These processes are reduced in RAC1 inactivated models of
    ovarian cancer. Gonzalez-Villasana, et al. Clin Cancer Res, 2015.   Proteins on
    this pathway have targeted assays available via the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP3303
    ).
  keywords:
  - ABIN-1
  - ABIN-2
  - ABIN-3
  - AKT
  - ANG1
  - ANG2
  - ANG3
  - ANG4
  - BAD
  - BAX
  - CASP7
  - CASP9
  - CRK
  - CTNNB1
  - DOKR
  - EGFR
  - EIF4EBP1
  - ERBB2
  - ERK1
  - ERK2
  - FAK
  - FKHR
  - FN1
  - GRB14
  - GRB2
  - GRB7
  - HRAS
  - IKB
  - IKBKG
  - IKK1
  - IKK2
  - Integrin
  - JNK
  - KRAS
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MMP2
  - MSH2
  - MYC
  - NCK1
  - NFKB1
  - NOS1
  - NOS2
  - NRAS
  - PAK1
  - PI3K / p110
  - PIK3 / p85
  - PIK3R
  - PIP2
  - PIP3
  - PXN
  - RAC1
  - RAD51
  - RASA1
  - RELA
  - RS1
  - SAPK
  - SHP2
  - SOS1
  - SRC
  - STAT3
  - STAT5A
  - STAT5B
  - STMN1
  - Survivin
  - TEK
  - TIE1
  - TP53
  - YAP1
  license: CC0
  name: RAC1/PAK1/p38/MMP2 pathway
seo: CreativeWork
title: RAC1/PAK1/p38/MMP2 pathway
wpid: WP3303
---